Rose Marino Email

Chief Medical Officer . Glycomine

Current Roles

Employees:
24
Revenue:
$1.9M
About
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. Glycomine’s lead drug candidate, GLM101, is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.
Glycomine Address
733 Industrial Road
San Carlos, CA
Glycomine Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.